Latest Trials Latest NewsFAQ

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer

Phase 1

Active, not recruiting

Conditions: Stage IV Small Cell Lung Cancer

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Radiation: Stereotactic body radiation therapy

First Posted Date: 2017-07-21

Last Posted Date: 2024-01-29

Lead Sponsor: University of Chicago

Target Recruit Count: 78

Registration Number: NCT03223155

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Early Childhood Nutrition and Adult Outcomes in India

Completed

Conditions: Nonhealth Outcomes

Interventions: Dietary Supplement: Upma

First Posted Date: 2017-07-02

Last Posted Date: 2017-07-11

Lead Sponsor: University of Chicago

Target Recruit Count: 1360

Registration Number: NCT03207321

Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer

Phase 1

Terminated

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Nivolumab
Drug: Ipilimumab

First Posted Date: 2017-06-29

Last Posted Date: 2021-06-10

Lead Sponsor: University of Chicago

Target Recruit Count: 14

Registration Number: NCT03203304

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Vasopressor SAT Study

Active, not recruiting

Conditions: Delirium
Critical Illness
Low Blood Pressure

Interventions: Other: sedation awakening trial

First Posted Date: 2017-06-09

Last Posted Date: 2024-07-26

Lead Sponsor: University of Chicago

Target Recruit Count: 800

Registration Number: NCT03182335

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

CommunityRx for Hunger: A Hospital-Based Intervention

Not Applicable

Withdrawn

Conditions: Clinical Trial
Health-Related Quality of Life
Food Insecurity
Caregivers
Hunger
Patient Satisfaction

Interventions: Other: CommunityRx-H

First Posted Date: 2017-06-02

Last Posted Date: 2020-04-24

Lead Sponsor: University of Chicago

Registration Number: NCT03173794

Project WERK (Wellness Encouragement Respect Kinship)

Not Applicable

Completed

Conditions: HIV Prevention

Interventions: Other: WERK Supportive Contact

First Posted Date: 2017-05-10

Last Posted Date: 2024-05-10

Lead Sponsor: University of Chicago

Target Recruit Count: 290

Registration Number: NCT03148171

Locations: 🇺🇸
Chicago Center for HIV Elimination, Chicago, Illinois, United States

The Value of Health Insurance: A Field Experiment in India

Not Applicable

Completed

Conditions: Health Expenditure

Interventions: Other: RSBY Health Insurance

First Posted Date: 2017-05-08

Last Posted Date: 2019-07-01

Lead Sponsor: University of Chicago

Target Recruit Count: 11089

Registration Number: NCT03144076

Cardiogenic Shock Intravascular Cooling Trial

Not Applicable

Completed

Conditions: Cardiogenic Shock

Interventions: Device: IVTM™ System
Device: Quattro® Catheter

First Posted Date: 2017-05-05

Last Posted Date: 2023-04-12

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT03141255

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Metoprolol to Reduce Perioperative Myocardial Injury

Phase 3

Completed

Conditions: Heart Diseases

Interventions: Drug: Metoprolol Tartrate
Drug: Placebo

First Posted Date: 2017-05-03

Last Posted Date: 2023-10-23

Lead Sponsor: University of Chicago

Target Recruit Count: 170

Registration Number: NCT03138603

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer

Phase 2

Completed

Conditions: HPV-Related Squamous Cell Carcinoma
HNSCC

Interventions: Drug: nab-paclitaxel
Procedure: Transoral robotic surgery (TORS)
Drug: Carboplatin
Drug: Cisplatin
Radiation: Adjuvant RT
Drug: Nivolumab
Drug: Hydroxyurea
Drug: 5-FU
Drug: Dexamethasone
Drug: Famotidine
Drug: Diphenhydramine
Drug: Paclitaxel
Radiation: Chemoradiotherapy

First Posted Date: 2017-04-11

Last Posted Date: 2024-10-11

Lead Sponsor: University of Chicago

Target Recruit Count: 76

Registration Number: NCT03107182

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy